FDA Addresses Societies’ Misinformation On Breast Implant Cancer Risks
This article was originally published in The Gray Sheet
CDRH Director Jeffrey Shuren contacted two plastic surgery societies the week of Feb. 21 to discuss a webinar sponsored by the groups that may have downplayed the association between breast implants and cancer.
You may also be interested in...
In response to data suggesting that breast implants may be associated with a rare form of cancer, FDA plans to work with manufacturers on revised product labeling, the agency announced Jan. 26.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.